JP Patent

JP7341060B2 — Ｍａｐｋ経路の活性化に関連付けられる癌の処置のための方法及び医薬組成物

Assigned to Centre Hospitalier Universitaire de Toulouse · Expires 2023-09-08 · 3y expired

What this patent protects

Patent listed against Mektovi.

Drugs covered by this patent

Patent Metadata

Patent number
JP7341060B2
Jurisdiction
JP
Classification
—
Expires
2023-09-08
Drug substance claim
No
Drug product claim
No
Assignee
Centre Hospitalier Universitaire de Toulouse
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.